Telsey Advisory lowered the firm’s price target on RH (RH) to $185 from $220 and keeps a Market Perform rating on the shares. The firm remains positive on the company’s product transformation but remains concerned about the impact on profitability from tariffs, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RH:
- Morning Movers: Cannabis stocks higher after reports of reclassification
- RH price target lowered to $200 from $265 at TD Cowen
- RH price target lowered to $188 from $215 at UBS
- RH price target lowered to $180 from $235 at Baird
- RH’s Strong Free Cash Flow and Operating Leverage Justify Buy Rating Amid Growth Potential